These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1611855)

  • 1. The postantibiotic suppressive effect of L-ofloxacin, an optically active isomer of ofloxacin.
    Fu KP; Foleno B; Rosenthale ME
    Diagn Microbiol Infect Dis; 1992; 15(4):375-8. PubMed ID: 1611855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postantibiotic effect of ciprofloxacin compared with that of five other quinolones.
    Minguez F; Ramos C; Barrientos S; Loscos A; Prieto J
    Chemotherapy; 1991; 37(6):420-5. PubMed ID: 1760941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-vitro comparison of the post-antibiotic effect of vancomycin and teicoplanin.
    Cooper MA; Jin YF; Ashby JP; Andrews JM; Wise R
    J Antimicrob Chemother; 1990 Aug; 26(2):203-7. PubMed ID: 2145256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of temafloxacin against gram-positive cocci including methicillin-resistant Staphylococcus aureus.
    Fuchs PC
    Am J Med; 1991 Dec; 91(6A):15S-18S. PubMed ID: 1662886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postantibiotic effect of DU-6859a and levofloxacin as compared with ofloxacin.
    Houston AK; Jones RN
    Diagn Microbiol Infect Dis; 1994 Jan; 18(1):57-9. PubMed ID: 8026158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activities of DX-619 and comparison quinolones against gram-positive cocci.
    Wickman PA; Black JA; Moland ES; Thomson KS
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2255-7. PubMed ID: 16723599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of sparfloxacin and three other fluoroquinolones against methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis.
    Smith KR; Cobbs CG
    Eur J Clin Microbiol Infect Dis; 1992 Jan; 11(1):55-8. PubMed ID: 1314175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of l-ofloxacin against norfloxacin-resistant coagulase-negative staphylococci.
    Foleno B; Fu KP
    Diagn Microbiol Infect Dis; 1992 Aug; 15(6):557-9. PubMed ID: 1330420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of levofloxacin against coagulase-positive and -negative staphylococci.
    Cafiso V; Messina C; Santagati M; Campanile F; Bonfiglio G; Stefani S
    Drugs Exp Clin Res; 2001; 27(3):107-11. PubMed ID: 11447768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The fluoroquinolones exert a reduced rate of kill against Enterococcus faecalis.
    Lewin CS; Morrissey I; Smith JT
    J Pharm Pharmacol; 1991 Jul; 43(7):492-4. PubMed ID: 1682462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Post-antibiotic effect of ciprofloxacin alone and in combination on Streptococcus faecalis].
    Zuccarelli M; Simeon de Buochberg M; Maillols H; Dusart G; Attisso MA
    Pathol Biol (Paris); 1988 May; 36(5):410-3. PubMed ID: 3136423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of CP-74667 compared with four other fluoroquinolones.
    Jones RN; Erwin ME
    Diagn Microbiol Infect Dis; 1992 Aug; 15(6):531-6. PubMed ID: 1330419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro postantibiotic effect of roxithromycin and erythromycin against gram-positive cocci.
    Chang JC; Hsueh PR; Young C
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1992 Nov; 25(4):276-84. PubMed ID: 1342645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Current status of resistance of bacteria to pefloxacin in hospital units. Cross resistance with ofloxacin and ciprofloxacin. Results of a multicenter study].
    Thabaut A; Meyran M; Fabre R; Dellamonica P; Moreau N
    Pathol Biol (Paris); 1994 May; 42(5):369-74. PubMed ID: 7824298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postantibiotic effect of meropenem and ciprofloxacin in the presence of 5-fluorouracil.
    Nyhlén A; Ljungberg B; Nilsson-Ehle I; Odenholt I
    Chemotherapy; 2002 Sep; 48(4):182-8. PubMed ID: 12218265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human serum enhances the postantibiotic effect of fluoroquinolones against Staphylococcus aureus.
    Davidson RJ; Zhanel GG; Phillips R; Hoban DJ
    Antimicrob Agents Chemother; 1991 Jun; 35(6):1261-3. PubMed ID: 1929278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of temperature on the bactericidal activities of ciprofloxacin and levofloxacin against Staphylococcus aureus and Staphylococcus epidermidis.
    Parte AC; Smith JT
    Microbios; 1994; 79(319):87-95. PubMed ID: 7968664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative antimicrobial activity of RP 59,500 (quinupristin-dalfopristin), the first semisynthetic injectable streptgramin, against gram-positive cocci and other recent clinical pathogens].
    Nakashio S; Iwasawa H; Iino S; Shimada J
    Jpn J Antibiot; 1997 Oct; 50(10):844-53. PubMed ID: 9412874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The antibacterial effect of ciprofloxacin, ofloxacin and norfloxacin in vitro].
    Rotter M; Hirschl AM
    Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Nov; 270(1-2):145-52. PubMed ID: 3223134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro antibacterial activity of DR-3355, the S-(-)-isomer of ofloxacin.
    Fujimoto T; Mitsuhashi S
    Chemotherapy; 1990; 36(4):268-76. PubMed ID: 2174762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.